Applied Clinical Trials-11-01-2006

Key screening, training, and communications techniques for putting together a strong staff.

There's plenty to tackle this month, including a debate over efficacy, new ARDS guidelines, and evidence the EMEA is listening.

Under IOM's plan, a "lifecycle approach" to drug evaluation would change FDA's pre- and postapproval policies.

India continues to gain the attention of pharmaceutical companies looking for a place to conduct clinical trials because of the country's reputation for fast subject recruitment rates. But as Jane Barrett reveals, sometimes the country's clinical trial participants are more uninformed than informed.

Software disentangles delivery efficacy from drug efficacy, improving trial results

Michael Murphy, President and CEO of Gentris Corporation, answers questions about his company's recent expansion into Japan.

ACT would like to welcome Somesh Nigam to our Editorial Advisory Board and introduce him to our readers.

Photo highlights from ExL Pharma's September Conference: Merging eHR & EDC.

Practical issues that accompany the decision to integrate PDAs and other handheld devices.

Release takes adverse event reporting to a new level, complies with FDA's new rules

Document management suite gets training records tool with eCTD capabilities slated for V4.0

Successful efforts of the organ donation sector could serve as a model for rebuilding public trust.

What has the industry and the FDA accomplished this year and what still needs to be done?

From stress levels to job satisfaction, ACT's first salary survey provides an inside look at our industry today.

A review of the essential requirements for good project leaders and the crucial role they must play.